chinese glp 1 💊🧬China has approved the world's first cAMP-biased GLP-1 receptor agonist for type 2 diabetes, developed by Hangzhou-based Sciwind Biosciences. Approved on Jan. 30, Ennoglutide Injection (Xianyida®) is the first Class innovative GLP-1 Supplement, 16-in-1 GLP-1 Liquid
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5


























